http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_ca1631fd2a0ed73e24453a6ef91535a8
Outgoing Links
| Predicate | Object |
|---|---|
| family-name | Moore |
| name | Malcolm A. S. Moore Malcolm A S Moore |
| given-name | Malcolm A. S. Malcolm A S |
| organization-name | Cell Biology Program, Sloan-Kettering Institute for Cancer Research, New York, NY 10065; and Walter and Eliza Hall Institute of Medical Research, Royal Melbourne Hospital From the , Victoria 3050, Australia Cell Biology Program, Sloan-Kettering Institute for Cancer Research, 1275 York Avenue, New York, NY 10065, USA. From the Laboratory of Molecular Aspects of Hematopoiesis and the Laboratory of Developmental Hematopoiesis, Sloan-Kettering Institute, New York, NY; and the Department of Medicine, Memorial Sloan-Kettering Cancer Center, New York, NY. From the Laboratory of Immunogenetics, The Walter and Eliza Hall Institute of Medical Research, Post Office, The Royal Melbourne Hospital, Victoria 3050, Australia Sloan Kettering Cancer Institute Department of Developmental Hematopoiesis, Sloan-Kettering Institute for Cancer Research, New York 10021 Developmental Hematopoiesis Laboratory, Cell Biology and Genetics Program, Memorial Sloan–Kettering Cancer Center, New York, NY 10021; and Division of Hematology and Oncology, Cornell University Medical College, New York, NY 10021 Cell Biology Program, Memorial Sloan-Kettering Cancer Center, New York, NY; and Cell Biology Program, Department of Surgery Memorial Sloan-Kettering Cancer Center, New York, New York From the Laboratory of Developmental Hematopoiesis, Cell Biology Program, and the Department of Medicine, Memorial Sloan-Kettering Cancer Center, New York; the Departments of Pathology and Microbiology and Immunology, Weill Medical College, Cornell University, New York, NY; and Geron Corporation, Menlo Park, CA. Laboratory of Developmental Hematopoiesis and Laboratory of Molecular Hematology, Memorial Sloan-Kettering Cancer Center, New York, NY 10021. From the Laboratory of Developmental Hematopoiesis, Cell Biology Program, Memorial Sloan-Kettering Cancer Center, New York, NY; Myeloma Institute for Research and Therapy, University of Arkansas for Medical Sciences, Little Rock; and Cancer Research and Biostatistics, Seattle, WA. From the Division of Hematology-Oncology, Weill Medical College of Cornell University, New York, NY; Division of Molecular, Cell Biology and Immunology, ImClone Systems, New York, NY; Department of Cardiothoracic Surgery, Columbia-Presbyterian Medical Center, New York, NY; and Division of Developmental Hematopoiesis, Sloan Kettering Cancer Center, New York, NY. James Ewing Laboratory of Developmental Hematopoiesis, Laboratory of BioOrganic Chemistry, and Laboratory of NeuroOncology, Memorial Sloan-Kettering Cancer Center, New York, NY 10021; and Departments of Pathology and Microbiology and Immunology, Weill Medical College, Cornell University, New York, NY 10021 From the Division of Hematology-Oncology, Weill Medical College of Cornell University, Ithaca, NY; the Bioengineering Program, Hofstra University, Hempstead, NY; Oncology Research, Novartis Pharma AG, Basel, Switzerland; and the Division of Developmental Hematopoiesis, Sloan Kettering Cancer Center, New York, NY. Molecular Biology and Cell Biology Programs, Memorial Sloan-Kettering Cancer Center and Sloan-Kettering Division, Graduate School of Medical Sciences, Cornell University, 1275 York Avenue, New York, NY 10021 From the Laboratory of Developmental Hematopoiesis/Cell Biology Program, the Department of Medicine, and the Department of Pathology, Memorial Sloan-Kettering Cancer Center, New York, NY; and ImClone Systems, New York, NY. From the Division of Pulmonary and Critical Care Medicine, Weill Medical College of Cornell University—New York Presbyterian Hospital; James Ewing Laboratory of Developmental Hematopoiesis, Memorial Sloan-Kettering Cancer Center; and Institute of Genetic Medicine,Weill Medical College of Cornell University, New York, NY. Cell Biology Program, Memorial Sloan-Kettering Cancer Center, Sloan-Kettering Institute , New York, New York From the Laboratory of Developmental Hematopoiesis, Memorial Sloan–Kettering Cancer Center, New York, NY. From the James Ewing Laboratory of Developmental Hematopoiesis, Memorial Sloan-Kettering Cancer Center, New York, NY, and the Division of Pulmonary and Critical Care Medicine, Weill Medical College of Cornell University–New York Presbyterian Hospital, New York, NY. From the Laboratory of Developmental Hematopoiesis, Cell Biology Program, Memorial Sloan-Kettering Cancer Center, New York, NY; and the Department of Experimental and Clinical Medicine, University of Catanzaro “Magna Graecia,” Catanzaro, Italy. Division of Hematology-Oncology, Weill Medical College of Cornell University, New York, NY 10021; ImClone Systems Incorporated, New York, NY 10014; Sloan-Kettering Institute for Cancer Research, New York, NY 10021; and Sapporo City General Hospital, 060-8604 Sapporo, Japan Department of Medicine, University of Miami School of Medicine and The Howard Hughes Medical Institute, Miami, Fla. 33152, and The Walter and Eliza Hall Institute of Medical Research, Melbourne, Australia.; Cancer Research Unit, The Walter and Eliza Hall Institute of Medical Research, Melbourne, Australia. From the University Medical Center Groningen, Department of Hematology, Groningen, The Netherlands; and Developmental Hematopoiesis, Memorial Sloan-Kettering Cancer Center, New York, NY. Memorial Sloan-Kettering Cancer Center, New York, NY Cell Biology Program, Sloan-Kettering Institute, New York, NY From the Laboratory of Clinical Oncology, IRCC—Institute for Cancer Research and Treatment, Torino, Italy; James Ewing Laboratory of Developmental Hematopoiesis, Memorial Sloan-Kettering Cancer Center, New York, NY; and Department of Clinical Sciences, Section of Hemato-Oncology, University of Parma Medical School, Parma, Italy. Cancer Biology and Genetics Program, Cell Biology Program, Laboratory for Bioorganic Chemistry, Organic Synthesis Core Facility, Howard Hughes Medical Institute, Memorial Sloan-Kettering Cancer Center, 1275 York Avenue, New York, New York 10065, and Department of Chemistry, Columbia University, Havemeyer Hall, 3000 Broadway, New York, New York 10027 Moore Laboratory, Cell Biology Program, Memorial Sloan-Kettering Cancer Center, New York, New York, USA. Cell Biology, and Contribution from the Laboratory for Bioorganic Chemistry, Sloan-Kettering Institute for Cancer Research, 1275 York Avenue, New York, New York 10021, Department of Physiology, Weill Medical College of Cornell University, 1300 York Avenue, New York, New York 10021, Laboratory of Developmental Hematopoiesis, Cell Biology Program, Sloan-Kettering Institute for Cancer Research, New York, New York 10021, Analytical Core Facility, Sloan-Kettering Institute for Cancer Research, 1275 York Avenue, New York, New... 1 From the James Ewing Laboratory of Developmental Hematopoiesis, Sloan-Kettering Institute for Cancer Research; Division of Hematology-Oncology, Weill Medical College of Cornell University; and Division of Pulmonary and Critical Care Medicine, The New York Hospital–Cornell Medical Center, New York, NY; the Center for Molecular Biology and Genetics, and Department of Medical Chemistry, Faculty of Medicine, Kyoto University, Japan; and the Department of Pathology, Sapporo City General Hospital, Japan. The Memorial Sloan Kettering Cancer Center New York NY USA From the Laboratory of Molecular Hematopoiesis, Sloan-Kettering Institute; the Division of Hematologic Oncology, Memorial Sloan-Kettering Cancer Center; and the Laboratory of Developmental Hematopoiesis, Cell Biology Program, Sloan-Kettering Institute, New York, NY. |
Incoming Links
Total number of triples: 142.